Secukinumab biosimilar (Bio-Thera Solutions)

司库奇尤单抗生物类似药(百奥泰)

Report date: 2025/02/08 11:30:00

Base Information

Drug NameSecukinumab biosimilar (Bio-Thera Solutions)
Drug Alias NameBAT-2306
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandHungaryMainland China +[4
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBio-Thera Solutions Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A